Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06550297 · ClinicalTrials.gov registry record · NA

Medically Tailored Meals for Cardiovascular Health

A NA study of Blood Pressure and Diet, Healthy, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT06550297 is a NA study of Blood Pressure and Diet, Healthy that is actively recruiting participants, run by Columbia University. The registered enrollment target is 160 participants, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06550297, a NA study of Blood Pressure and Diet, Healthy, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial (RCT) will investigate novel approaches to enhance effectiveness, engagement, reach, and cost-effectiveness of medically tailored meals (MTM) programs for promoting cardiovascular health, focusing on economically disadvantaged New York City neighborhoods with a disparate burden of multiple cardiometabolic diseases. The main questions the RCT aims to answer are: 1. Does enhancing MTM programs, with culturally relevant cardiovascular health curriculum (including educational sessions on heart health, healthy diet, cooking demonstrations, recipes, gift bags with healthy ingredients and fresh produce, and addressing social needs) enhance program engagement and effectiveness in improving short-term healthy eating behaviors and clinical outcomes (HbA1c and blood pressure) among individuals with type 2 diabetes and elevated to high blood pressure who currently qualify for MTM programs? 2. Is the MTM program coupled with the cardiovascular health curriculum effective for improving healthy eating behaviors and clinical outcomes (HbA1c and blood pressure) among individuals with type 2 diabetes and elevated to high blood pressure who do not currently qualify for MTM programs and is a gradual reduction of MTM dosing an effective and sustainable approach for expanding reach of these programs? To answer question 1, 60 participants with type 2 diabetes and elevated to high blood pressure who currently qualify for MTM programs will be randomized into a group that receives the standard MTM program (10 MTMs/week for 8 months) or a group that receives the standard program plus the cardiovascular health curriculum. To answer question 2, 100 participants with type 2 diabetes and elevated to high blood pressure who do not currently qualify for MTM programs (due to not having advanced disease with complications) will be randomized into a group that receives the standard MTM program (10 MTMs/week for 8 months) plus the cardiovascular health curriculum or a

Interventions

  • BEHAVIORAL Medically Tailored Meals and Nutritional Counseling
  • BEHAVIORAL Cardiovascular Health Promotion Educational Program

Study Locations (1)

New York

  • Columbia University Mailman School of Public Health - New York

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2024-08-28
Est. Completion 2026-06
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT06550297

The ClinicalTrials.gov registry entry for NCT06550297 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 101 other Blood Pressure trials with a reported enrollment target (44% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Medically Tailored Meals and Nutritional Counseling is the first listed.

NCT06550297 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06550297 about?

NCT06550297 is a clinical study titled "Medically Tailored Meals for Cardiovascular Health". This randomized clinical trial (RCT) will investigate novel approaches to enhance effectiveness, engagement, reach, and cost-effectiveness of medically tailored meals (MTM) programs for promoting cardiovascular health, focusing on economically disadvantaged New York City neighborhoods with a dispara...

What is the current status of trial NCT06550297?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-08-28. Estimated completion is 2026-06.

What conditions does trial NCT06550297 study?

This clinical trial studies the following conditions: Blood Pressure, Diet, Healthy, HbA1c.

What interventions are being tested in trial NCT06550297?

The interventions under investigation include: Medically Tailored Meals and Nutritional Counseling (BEHAVIORAL), Cardiovascular Health Promotion Educational Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06550297?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06550297 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.